Dario Vignali

Co-Founder at Tizona Therapeutics, Inc.

Dario Vignali

Dario Vignali

Co-Founder at Tizona Therapeutics, Inc.

Overview
Career Highlights

Tizona Therapeutics, Inc.

RelSci Relationships

301

Number of Boards

4

Relationships
RelSci Relationships are individuals Dario Vignali likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder at Jounce Therapeutics, Inc.

Relationship likelihood: Strong

Co-Founder at Celsius Therapeutics, Inc.

Relationship likelihood: Strong

Co-Founder at Tizona Therapeutics, Inc.

Relationship likelihood: Strong

Co-Founder at Tizona Therapeutics, Inc.

Relationship likelihood: Strong

President, Chief Executive Officer & Director at Potenza Therapeutics, Inc.

Relationship likelihood: Strong

Lloyd J. Old-Virginia & Daniel K. Ludwig Chair in Clinical Investigation, Chief, Melanoma & Immunotherapeutics Service, Director, Parker Institute for Cancer Immunotherapy, Msk & Associate Director, Ludwig Center for Cancer Immunotherapy at Memorial Sloan-Kettering Cancer Center

Relationship likelihood: Strong

Associate Professor of Neurology at Harvard University - Harvard Medical School

Relationship likelihood: Strong

Co-Founder at Oncorus, Inc.

Relationship likelihood: Strong

Co-Founder at Cancer Treatment Services International, Inc.

Relationship likelihood: Strong

Co-Director, Tumor Microenvironment Center at UPMC Cancer Institute

Relationship likelihood: Strong

Paths to Dario Vignali
Potential Connections via
Relationship Science
You
Dario Vignali
Co-Founder at Tizona Therapeutics, Inc.
Career History
Co-Director, Cancer Immunology Program
2014 - Current

UPMC Cancer Institute provides health care and insurance services. The company was founded in 1985 and is headquartered in Pittsburgh, PA.

Vice Chairman, Department of Immunology
2014 - Current

The University of Pittsburgh School of Medicine is a medical school located in Pittsburgh, Pennsylvania.

Co-Founder
Current

Tizona Therapeutics, Inc. is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Its products include anti-ccr4 antibody for the treatment of cancer, il-35 antagonists for the treatment of cancer, and il-35 agonists for the treatment of autoimmune diseases. The company was founded by Charles G. Drake, Vijay K. Kuchroo, Drew Pardoll, Dario Vignali, and Jedd Wolchok and is headquartered in South San Francisco, CA.

Boards & Committees
Member, Scientific Advisory Board
Current

Potenza Therapeutics, Inc. develops oncology programs and mechanisms for tumors detection. It is focusing on the discovery and development of novel immune-oncology therapeutics: molecules that stimulate the power of the immune system to fight cancer. The company was founded by Drew M. Pardoll and Daniel J. Hicklin in 2014 and is headquartered in Cambridge, MA.

Investments
Details Hidden

Tizona Therapeutics, Inc. is an immunology company harnessing the power of the immune system to develop treatments for cancer and autoimmune diseases. Its products include anti-ccr4 antibody for the treatment of cancer, il-35 antagonists for the treatment of cancer, and il-35 agonists for the treatment of autoimmune diseases. The company was founded by Charles G. Drake, Vijay K. Kuchroo, Drew Pardoll, Dario Vignali, and Jedd Wolchok and is headquartered in South San Francisco, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Dario Vignali. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Dario Vignali's profile does not indicate a business or promotional relationship of any kind between RelSci and Dario Vignali.